These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10735605)

  • 21. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.
    Momoi H; Itoh T; Nozaki Y; Arima Y; Okabe H; Satoh S; Toda Y; Sakai E; Nakagawara K; Flemming P; Yamamoto M; Shimahara Y; Yamaoka Y; Fukumoto M
    J Hepatol; 2001 Aug; 35(2):235-44. PubMed ID: 11580146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
    Walker SL; McCormick PA
    Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in primary sclerosing cholangitis: ιmplications for cholangiocarcinogenesis.
    Ishii Y; Sasaki T; Serikawa M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Shimizu A; Tsuboi T; Chayama K
    Int J Oncol; 2013 Oct; 43(4):1073-9. PubMed ID: 23900502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
    Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.
    Boberg KM; Jebsen P; Clausen OP; Aabakken L; Brekke I; Schrumpf E
    J Hepatol; 2003 Sep; 39(3):453. PubMed ID: 12927935
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
    Voigtländer T; Wlecke J; Negm AA; Lenzen H; Manns MP; Lankisch TO
    J Clin Gastroenterol; 2014; 48(10):866-9. PubMed ID: 24440929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.
    Komori J; Marusawa H; Machimoto T; Endo Y; Kinoshita K; Kou T; Haga H; Ikai I; Uemoto S; Chiba T
    Hepatology; 2008 Mar; 47(3):888-96. PubMed ID: 18306229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
    Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
    Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma.
    Taniai M; Higuchi H; Burgart LJ; Gores GJ
    Gastroenterology; 2002 Oct; 123(4):1090-8. PubMed ID: 12360471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
    Lazaridis KN
    Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
    [No Abstract]   [Full Text] [Related]  

  • 40. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
    Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
    Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.